Halda Therapeutics Funding: $202M Raised, Series B (2024)
Halda Therapeutics is a Biotech company. It has raised $202M in total funding. Latest round: Series B.
Halda Therapeutics funding overview
Halda Therapeutics is a Biotech company. Halda Therapeutics has raised $202M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for Halda Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Canaan Partners, Access Biotechnology, Connecticut Innovations, Elm Street Ventures, 6 Dimensions Capital, Access Industries. 6 distinct backers are named across the disclosed rounds.
Halda Therapeutics at a glance
Total raised
$202M
Latest round
Series B
Latest round date
August 2024
Industry
Biotech
Notable investors
Canaan Partners, Access Biotechnology, Connecticut Innovations, Elm Street Ventures, 6 Dimensions Capital, Access Industries
Frequently asked about Halda Therapeutics funding
How much has Halda Therapeutics raised?
Halda Therapeutics has raised $202M in total disclosed funding across the rounds on record.
Who has invested in Halda Therapeutics?
Canaan Partners, Access Biotechnology, Connecticut Innovations, Elm Street Ventures, 6 Dimensions Capital, Access Industries are named among the investors backing Halda Therapeutics.
What was the latest Halda Therapeutics funding round?
The most recent disclosed round is a Series B, announced in August 2024.
Where is Halda Therapeutics based?
No headquarters location is disclosed for Halda Therapeutics.
What sector does Halda Therapeutics operate in?
Halda Therapeutics is tracked under Biotech, with $202M in disclosed funding.
When did Halda Therapeutics last raise?
The last disclosed Halda Therapeutics round closed in August 2024 at Series B.
We update the Halda Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
